Status:

COMPLETED

The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation

Lead Sponsor:

Oregon Health and Science University

Conditions:

Obesity

Addison's Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Replacing glucocorticoid in a dose dependent manner (including doses within the physiological range) to subjects with adrenal insufficiency will increase visceral fat accumulation independently of tot...

Detailed Description

To measure total fat mass by DEXA scan, central (visceral) fat accumulation, insulin sensitivity by FSIVGTT, lipid levels, and adipocyte gene expression in subjects with AI receiving increasing doses ...

Eligibility Criteria

Inclusion

  • Subjects with complete adrenal failure as defined as spontaneous serum cortisol of levels less than 5 g/dl after 12 hours without glucocorticoid replacement and peak serum cortisol of \< 5 g/dl 60 minutes after a 250 g ACTH stimulation test.
  • Subjects who are at their usual weight (weight stable for at least 1 year)
  • Subjects on stable replacement doses of any required hormone such as thyroid, sex hormones, mineralocorticoid replacement, growth hormone, and hydrocortisone for at least 6 months, and 4) have a normal body weight (BMI 19-27 kg/m2).

Exclusion

  • Possible confounders on body weight and insulin resistance
  • Age less than 18 to exclude those who might be experiencing alterations in cortisol production or weight as a result of adolescent growth.
  • Subjects who exercise \> 30 minutes/day, 3 times a week.
  • Smokers.
  • Heavy alcohol drinkers (\> 2 drinks/ day).
  • Subjects with medical diagnosis including diabetes, heart disease, and cancer.
  • Subjects with psychiatric illness (i.e., depression, psychosis, bipolar, schizophrenia; or are taking medications for these disorders).

Key Trial Info

Start Date :

August 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2004

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00688987

Start Date

August 1 2000

End Date

August 1 2004

Last Update

June 5 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oregon Health & Science University

Portland, Oregon, United States, 97239